Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 31

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 31
---
 categories of (i) political donations to political parties and/or independent election candidates, (ii) political donations to political organisations other than political parties, and (iii) political expenditure. Vote Required The affirmative vote of holders representing a simple majority of the total voting rights of shareholders present in person or by proxy who (being entitled to vote) vote on the matter will be required to pass this resolution. THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE RESOLUTION TO MAKE POLITICAL DONATIONS OR INCUR POLITICAL EXPENDITURE. 22 TABLE OF CONTENTS BACKGROUND TO RESOLUTIONS 12 AND 13—SHARE ISSUANCE AUTHORIZATION Introduction Pursuant to the Companies Act, our directors may only allot shares or grant rights to subscribe for or convert any security into shares (“Share Rights”) (other than pursuant to an employees’ share scheme as defined in the Companies Act) if authorized to do so by our shareholders. If our shareholders authorize our directors to allot shares or grant Share Rights, the Companies Act requires us, where the allotment is for cash, to offer them first to our existing shareholders in proportion to their existing holdings, unless the shareholders have sanctioned the disapplication of their statutory rights of pre-emption in respect of such allotment or grant of Share Rights. In this proxy statement, we refer to the share allotment authority and pre-emption disapplication collectively as the “share issuance authorization.” At our general meeting held on February 3, 2021 (“2021 GM”), our shareholders authorized our directors to allot shares or to grant Share Rights up to an aggregate nominal value of £150,000 (equal to 75 million ordinary shares with a nominal value of £0.002 each) and disapplied the statutory pre-emption rights in respect of such allotments, in each case for a period of up to five years. The authorities granted at the 2021 GM are due to expire on February 3, 2026. We ask our shareholders to approve under resolutions 12 and 13, for a period of up to five years until May 14, 2030, the allotment of shares and grant of Share Rights up to an aggregate nominal amount of £150,000 on a non-pre-emptive basis. Our board of directors believe that it is important for the board to have the flexibility to raise funds through the issue of new equity as required to finance our working capital requirements and growth plans. Resolutions 12 and 13 are, in our directors’ view,